Anti-KIR blocking antibodies has led to important therapeutic implications in NK cell immunotherapy. 1-7F9 is a human monoclonal antibody that cross reacts with KIR2DL-1, -2, -3 and prevents their ...

“We connect NK cells with tumor cells so they can destroy ... Innate Pharma’s therapies mark the dawn of a new generation of immunotherapy agents. “For the last 10 years, I think ...

When the researchers introduced NK cells into the cell cultures ... that AHA-1031 could have potential as a new type of cancer immunotherapy. If these findings are confirmed in future studies ...

Prof. MENG Guangxun's team from the Shanghai Institute of Immunity and Infection of the Chinese Academy of Sciences, and collaborators, have revealed a novel mechanism whereby a short form of IL-18, ...

Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.